Creating Outstanding Pharmaceutical Companies



Accelerated Drug Approval

Orphan Drug Approval

Unapproved to Approved

Central Nervous System

Ricanto creates outstanding pharmaceutical companies acquiring the rights to undervalued, under-recognized or challenging pharmaceutical assets. Ricanto companies are focused on excellence, cost-effectiveness, meeting unmet medical needs and patient outcomes.

With a track record of success and superior returns to its investors/shareholders, Ricanto provides operational and financial capital to derisk and optimize companies prior to commercialization.